喀麦隆使用即时检测技术进行社区病毒性肝炎筛查的成本。
Costs of Community-Based Viral Hepatitis Screening in Cameroon Using Point-of-Care Technologies.
作者信息
Tazinkeng Nkengeh N, Mohareb Amir M, Asombang Akwi W, Hyle Emily P
机构信息
Department of Population Health Research, Health Education and Research Organization, Buea, Cameroon.
Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.
出版信息
Open Forum Infect Dis. 2024 Jul 3;11(7):ofae378. doi: 10.1093/ofid/ofae378. eCollection 2024 Jul.
Abstract
This cost analysis of a community-based viral hepatitis screening program in Cameroon found an investment of $3.52 per person screened, $50.63 per new diagnosis of hepatitis B, $159.45 per new diagnosis of hepatitis C, and $47.97 per new diagnosis of either hepatitis B or C.
摘要
这项针对喀麦隆一项基于社区的病毒性肝炎筛查项目的成本分析发现，每筛查一人的投资为3.52美元，每例新增乙肝诊断的成本为50.63美元，每例新增丙肝诊断的成本为159.45美元，每例新增乙肝或丙肝诊断的成本为47.97美元。
相似文献
1
Costs of Community-Based Viral Hepatitis Screening in Cameroon Using Point-of-Care Technologies.喀麦隆使用即时检测技术进行社区病毒性肝炎筛查的成本。
Open Forum Infect Dis. 2024 Jul 3;11(7):ofae378. doi: 10.1093/ofid/ofae378. eCollection 2024 Jul.
2
Screening, diagnosis and care cascade for viral hepatitis B and C in Yaoundé, Cameroon: a qualitative study of patients and health providers coping with uncertainty and unbearable costs.喀麦隆雅温得地区乙型和丙型病毒性肝炎的筛查、诊断及治疗流程：一项关于患者和医疗服务提供者应对不确定性和高昂费用的定性研究
BMJ Open. 2019 Mar 20;9(3):e025415. doi: 10.1136/bmjopen-2018-025415.
3
Factors associated with hepatitis B and C among adults in Buea, Cameroon: A community-based cross-sectional study.喀麦隆布埃亚成年人乙型和丙型肝炎相关因素：一项基于社区的横断面研究。
Liver Int. 2022 Nov;42(11):2396-2402. doi: 10.1111/liv.15390. Epub 2022 Aug 24.
4
Cost-utility analysis of four WHO-recommended sofosbuvir-based regimens for the treatment of chronic hepatitis C in sub-Saharan Africa.撒哈拉以南非洲地区四种世界卫生组织推荐的索非布韦为基础的治疗慢性丙型肝炎方案的成本效用分析。
BMC Health Serv Res. 2022 Mar 5;22(1):303. doi: 10.1186/s12913-021-07289-0.
5
Genetic diversity, viraemic and aminotransferases levels in chronic infected hepatitis B patients from Cameroon.喀麦隆慢性乙型肝炎感染患者的基因多样性、病毒血症及转氨酶水平
BMC Res Notes. 2016 Feb 22;9:117. doi: 10.1186/s13104-016-1916-7.
6
Prevalence of viral and non-viral hepatitis in Menoua Division, West Region, Cameroon: a retrospective hospital-based study.喀麦隆西部地区梅努阿分区病毒性和非病毒性肝炎的患病率：一项基于医院的回顾性研究。
Pan Afr Med J. 2019 Apr 29;32:212. doi: 10.11604/pamj.2019.32.212.16495. eCollection 2019.
7
Hepatitis B infection in the rural area of Dschang, Cameroon: seroprevalence and associated factors.喀麦隆杜阿拉农村地区的乙型肝炎感染：血清流行率及相关因素。
Pan Afr Med J. 2020 Aug 28;36:362. doi: 10.11604/pamj.2020.36.362.17787. eCollection 2020.
8
Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis.冈比亚基于社区的慢性乙型肝炎筛查和治疗的成本效益：经济建模分析。
Lancet Glob Health. 2016 Aug;4(8):e568-78. doi: 10.1016/S2214-109X(16)30101-2.
9
[Seroprevalence of hepatitis B and C viruses, HIV-1/2 and syphilis among blood donors in the Yaoundé Central Hospital in the centre region of Cameroon].[喀麦隆中部地区雅温得中心医院献血者中乙型和丙型肝炎病毒、HIV-1/2及梅毒的血清流行率]
Transfus Clin Biol. 2016 May;23(2):72-7. doi: 10.1016/j.tracli.2015.11.008. Epub 2016 Jan 11.
10
Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon.喀麦隆埃代阿地区初次献血者人群中人类免疫缺陷病毒、乙型肝炎和丙型肝炎病毒以及梅毒感染的血清流行病学研究。
Int J Infect Dis. 2013 Oct;17(10):e832-7. doi: 10.1016/j.ijid.2012.12.007. Epub 2013 Jan 11.
本文引用的文献
1
Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis.在西非冈比亚，对 HBV 感染者进行抗病毒治疗的全人群策略与靶向策略的成本效益分析。
Lancet Glob Health. 2024 Jan;12(1):e66-e78. doi: 10.1016/S2214-109X(23)00467-9.
2
Impact of hepatitis C virus point-of-care RNA viral load testing compared with laboratory-based testing on uptake of RNA testing and treatment, and turnaround times: a systematic review and meta-analysis.即时检测与实验室检测丙型肝炎病毒 RNA 病毒载量对 RNA 检测和治疗的影响，以及周转时间：系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2023 Mar;8(3):253-270. doi: 10.1016/S2468-1253(22)00346-6. Epub 2023 Jan 24.
3
Comparison between a rapid diagnostic test and dried blood spot-based immunoassay for hepatitis B surface antigen testing: Performance and cost implications in a population-based serosurvey in Vietnam.快速诊断检测与基于干血斑的免疫测定法在乙型肝炎表面抗原检测中的比较：在越南基于人群的血清学调查中对性能和成本的影响。
Int J Infect Dis. 2022 Dec;125:51-57. doi: 10.1016/j.ijid.2022.10.011. Epub 2022 Oct 12.
4
Factors associated with hepatitis B and C among adults in Buea, Cameroon: A community-based cross-sectional study.喀麦隆布埃亚成年人乙型和丙型肝炎相关因素：一项基于社区的横断面研究。
Liver Int. 2022 Nov;42(11):2396-2402. doi: 10.1111/liv.15390. Epub 2022 Aug 24.
5
A Rapid Point-of-Care Test for the Serodiagnosis of Hepatitis Delta Virus Infection.即时检测法用于乙型肝炎病毒感染血清学诊断的研究进展。
Viruses. 2021 Nov 26;13(12):2371. doi: 10.3390/v13122371.
6
Performing Country-led Economic Evaluations to Inform Immunization Policy: ProVac Experiences in Latin America and the Caribbean.开展由国家主导的经济评估以指导免疫政策：拉丁美洲和加勒比地区的ProVac经验。
Value Health Reg Issues. 2012 Dec;1(2):248-253. doi: 10.1016/j.vhri.2012.10.003. Epub 2012 Dec 12.
7
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.2016 年全球乙型肝炎病毒感染的流行率、治疗和预防：一项建模研究。
Lancet Gastroenterol Hepatol. 2018 Jun;3(6):383-403. doi: 10.1016/S2468-1253(18)30056-6. Epub 2018 Mar 27.
8
Innovative technologies for point-of-care testing of viral hepatitis in low-resource and decentralized settings.在资源匮乏和分散的环境中进行病毒性肝炎即时检测的创新技术。
J Viral Hepat. 2018 Feb;25(2):108-117. doi: 10.1111/jvh.12827. Epub 2017 Dec 27.
9
Seroprevalence of hepatitis B virus infection in Cameroon: a systematic review and meta-analysis.喀麦隆乙肝病毒感染的血清流行率：一项系统评价与荟萃分析。
BMJ Open. 2017 Jun 30;7(6):e015298. doi: 10.1136/bmjopen-2016-015298.
10
Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis.冈比亚基于社区的慢性乙型肝炎筛查和治疗的成本效益：经济建模分析。
Lancet Glob Health. 2016 Aug;4(8):e568-78. doi: 10.1016/S2214-109X(16)30101-2.
Zotero 插件